<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
									<item>
				<title>Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission</title>
				<description>INGELHEIM, Germany, March 27 /PRNewswire/ -- Boehringer Ingelheim today announced that the European Commission has 
granted marketing authorisation of the novel, oral direct thrombin 
inhibitor,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/624</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/624</guid>
				<pubDate>Thu, 27 Mar 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients</title>
				<description>MAIDENHEAD, England, July 7 /PRNewswire/ -- Wyeth Pharmaceuticals, today 3rd July, announced that it has received
EMEA marketing approval for Relistor(TM) (methylnaltrexone bromide)
subcutaneous...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1356</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1356</guid>
				<pubDate>Mon, 07 Jul 2008 18:56:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement</title>
				<description>GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that a Development and Licensing Agreement with Bionomics
(ASX: BNO) was signed, under...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237</guid>
				<pubDate>Wed, 18 Jun 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Roche Diagnostics Expands Availability of HCV Immunoassay</title>
				<description>ROTKREUZ, Switzerland, April 8 /PRNewswire/ -- Roche Diagnostics announced today that the Elecsys Anti-HCV (Hepatitis C
Virus) assay has received regulatory approval in Europe for the E 170
analyzer...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/745</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/745</guid>
				<pubDate>Tue, 08 Apr 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited</title>
				<description>NAPA, California, July 3 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1343</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1343</guid>
				<pubDate>Thu, 03 Jul 2008 14:30:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/public/news/mostviewedrss/275/Licensing_Marketing_Agreements" rel="self" type="application/rss+xml" />
	</channel>
</rss>
